Characteristics
Patients who received
any shock
(n = 380)
Patients who received any
appropriate shock
(n = 296)
Patients who received any
Inappropriate shock
(n=72)
Patients who received
no shock
(n = 40)
Age-Group in years
60-64
60-64
60-64
65-69
Ejection Fraction (%)
31±13
30.2 ± 12
33±14
28.4±10.4
NYHA Class -III
6.1 (23)
6.1 (18)
5.6 (4)
7.5 (3)
Male Gender
78.7 (299)
78.4 (232)
80.6 (58)
85 (34)
Congestive Heart Failure
49.2 (187)
49.3 (146)
50 (36)
55 (22)
Diabetes
21.8 (83)
22 (65)
16.7 (12)
37.5 (15)
Hypertension
53.4 (203)
56.7 (168)
40.3 (29)
57.5 (23)
Atrial Fibrillation/Flutter
24.7 (94)
22.6 (67)
31.9 (23)
15 (6)
History of Myocardial Infarction
70 (266)
70.2 (208)
69.4 (50)
85 (34)
History of CABG*
28.9 (110)
29.7 (88)
30.6 (22)
45 (18)
Smoking
22.6 (86)
21.3 (63)
29.2 (21)
27.5 (11)
ACE Inhibitor therapy
74.9 (285)
74.6 (221)
72.2 (52)
75 (30)
Aspirin therapy
60 (228)
60.1 (178)
61.1 (44)
65 (26)
Lipid lowering therapy
12.9 (49)
13.2 (39)
12.5 (9)
30 (12)
Beta Blocker therapy
35 (133)
33.5 (99)
40.3 (29)
40 (16)
[All values are % or n (mean ± SD)]
NYHA – New York Heart Association
*CABG – Coronary Artery Bypass Grafting
Table 1:
Baseline clinical characteristics of study groups.
